Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:35:08 2024-05-24 am EDT			After market 01:41:09 pm
39 ^EUR	+1.62%		38.98	-0.05%

05:54pm	European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	MT
05:26pm	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating	ZD

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating

May 08, 2024 at 05:42 am EDT

In a research note, Goldman Sachs analyst Richard Felton has maintained his recommendation on the stock with a Buy rating. No major update to the target price set at EUR 49 compared to EUR 50.

Latest news about Fresenius Medical Care AG

European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	11:54am	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating	11:26am	ZD
FMC, Fresenius and Davita rise after Ozempic news	07:43am	DP
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	May. 22	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	May. 21	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan	May. 20	ZD
Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative	May. 17	MT
Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	May. 16	MT
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating	May. 15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Jefferies	May. 14	ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	May. 13
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg	May. 13	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	May. 13	ZD
FRESENIUS MEDCARE : adjusted target price at Barclays	May. 13	CF
Fresenius Medical sees up to 2% US dialysis growth by year-end	May. 11	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	May. 08	DJ
Home REIT cuts borrowings, Genflow shares restored	May. 08	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	May. 08	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank sticks Neutral	May. 08	ZD
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	May. 08	DP
Dpa-AFX Overview: COMPANIES from 08.05.2024 - 15:15	May. 08	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating	May. 08	ZD
European Midday Briefing : Stocks Buoyed by Some Solid Earnings	May. 08	DJ
Fresenius makes strong start to the year - forecast raised thanks to subsidiary Kabi	May. 08	DP

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-07-29 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?

May 07, 2024 at 04:46 pm EDT

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

38.38 EUR

Average target price

39.84 EUR

Spread / Average Target

+3.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+2.74%	12.19B
HCA HEALTHCARE, INC.	+17.86%	82.59B
CVS HEALTH CORPORATION	-28.99%	69.86B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	26.5B
FRESENIUS SE & CO. KGAA	+3.06%	17.29B
LABCORP HOLDINGS INC.	-12.64%	16.61B
QUEST DIAGNOSTICS INCORPORATED	+2.39%	15.56B
NATERA, INC.	+74.19%	13.2B
REDE D'OR SÃO LUIZ S.A.	+0.76%	12.75B
TENET HEALTHCARE CORPORATION	+73.46%	12.6B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating

EPS Revisions